Primary tumor resection for initially staged IV breast cancer: An emphasis on programmed death-ligand 1 expression, promoter methylation status, and survival

Conventional therapy modalities for advanced breast cancer are problematic, whereas checkpoint blockade immunotherapy has been considered as a promising approach. This study aims to determine programmed death-ligand 1 (PD-L1) expression and methylation status of PD-L1 promoter in primary tumor tissu...

Descripción completa

Detalles Bibliográficos
Autores principales: Erol, Timuçin, İmamoğlu, Nazli Eylem, Aydin, Büşra, Taşkiran, Z. Ekim, Esendağli, Güneş, Kösemehmetoğlu, Kemal, Baykal, Ataç
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831165/
https://www.ncbi.nlm.nih.gov/pubmed/31415379
http://dx.doi.org/10.1097/MD.0000000000016773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831165/
https://www.ncbi.nlm.nih.gov/pubmed/31415379
http://dx.doi.org/10.1097/MD.0000000000016773

Ejemplares similares